Lncrna CASC11 aggravates diabetic nephropathy via targeting FoxO1

Yun Zhang1, Shuhan Shi1, Changda Lin1

  • 1Second Affiliated Hospital of Fujian Medical University, Department of Renal Medicine, Quanzhou, China.

PubMed
Abstract

Insights

Circular RNA CASC11 exacerbates diabetic nephropathy (DN) by regulating the forkhead transcription factor O1 (FoxO1). This study investigates CASC11's role in DN pathogenesis and its association with FoxO1.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Genetics

Background:

  • Diabetic nephropathy (DN) is a severe complication of diabetes.
  • The role of circular RNA CASC11 in DN progression is not fully understood.
  • Forkhead transcription factor O1 (FoxO1) is implicated in DN pathogenesis.

Purpose of the Study:

  • To investigate the biological effects of CASC11 in aggravating DN.
  • To explore the regulatory relationship between CASC11 and FoxO1 in DN.
  • To assess CASC11 as a potential biomarker for DN onset.

Main Methods:

  • Serum CASC11 and FoxO1 levels were measured in DN patients.
  • Receiver operating characteristic (ROC) curves analyzed CASC11's predictive value for DN.
  • Pearson correlation assessed the relationship between CASC11 and FoxO1.
  • In vitro experiments examined cell proliferation and migration in high glucose-induced mesangial cells.
  • Western blot analyzed protein levels of TGF-β1 and Smads.

Main Results:

  • Serum CASC11 levels were significantly altered in DN patients.
  • CASC11 showed potential in predicting DN onset.
  • A significant correlation was observed between CASC11 and FoxO1 levels.
  • CASC11 and FoxO1 intervention affected kidney mesangial cell proliferation and migration.
  • CASC11 and FoxO1 regulated TGF-β1 and Smad protein expression.

Conclusions:

  • CASC11 plays a crucial role in aggravating DN, partly through regulating FoxO1.
  • CASC11 may serve as a potential diagnostic biomarker for DN.
  • Targeting CASC11 and FoxO1 could offer therapeutic strategies for DN.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.5K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.3K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
971